Profile data is unavailable for this security.
About the company
Patterson Companies, Inc. is a value-added specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and United Kingdom animal health supply markets. The Company’s segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. It offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.
- Revenue in USD (TTM)6.53bn
- Net income in USD168.41m
- Incorporated1992
- Employees7.60k
- LocationPatterson Companies Inc1031 Mendota Heights RdSAINT PAUL 55120-1401United StatesUSA
- Phone+1 (651) 686-1600
- Websitehttps://www.pattersoncompanies.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings Corp | 1.57bn | 23.65m | 1.36bn | 3.95k | 59.00 | 0.8834 | 8.89 | 0.8652 | 0.2961 | 0.2961 | 20.02 | 19.77 | 0.399 | 1.55 | 5.81 | 396,986.10 | 0.6023 | 3.33 | 0.6618 | 3.68 | 61.54 | 63.67 | 1.51 | 7.99 | 2.10 | 5.88 | 0.5433 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| AtriCure Inc | 429.95m | -40.12m | 1.40bn | 1.20k | -- | 3.04 | -- | 3.26 | -0.8606 | -0.8606 | 9.22 | 9.49 | 0.7217 | 1.68 | 8.27 | 358,294.20 | -6.73 | -3.72 | -7.58 | -4.10 | 74.84 | 74.36 | -9.33 | -7.64 | 2.93 | -11.79 | 0.12 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Adapthealth Corp | 3.26bn | -692.75m | 1.52bn | 10.70k | -- | 1.01 | -- | 0.466 | -5.17 | -5.17 | 24.29 | 11.14 | 0.6714 | 22.22 | 8.12 | 304,741.80 | -14.15 | -4.34 | -15.89 | -4.89 | 18.63 | 18.28 | -21.07 | -6.47 | 0.9438 | 2.17 | 0.5866 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| STAAR Surgical Co | 332.94m | 16.61m | 1.55bn | 1.06k | 94.33 | 3.80 | 70.38 | 4.67 | 0.335 | 0.335 | 6.75 | 8.32 | 0.6984 | 2.13 | 3.54 | 315,286.00 | 3.49 | 6.77 | 3.99 | 7.90 | 79.24 | 76.89 | 4.99 | 9.16 | 5.21 | -- | 0.0003 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Warby Parker Inc | 719.93m | -45.90m | 1.77bn | 2.14k | -- | 5.36 | -- | 2.45 | -0.387 | -0.387 | 6.05 | 2.75 | 1.22 | 5.68 | 603.46 | 336,415.40 | -7.78 | -- | -9.68 | -- | 55.37 | 57.49 | -6.38 | -14.53 | 2.11 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Novocure Ltd | 549.96m | -168.70m | 1.93bn | 1.45k | -- | 5.33 | -- | 3.51 | -1.58 | -1.58 | 5.13 | 3.35 | 0.4639 | 3.62 | 8.11 | 378,502.40 | -14.23 | -7.74 | -16.44 | -8.95 | 75.83 | 77.22 | -30.67 | -14.69 | 6.22 | -- | 0.6437 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| Patterson Companies, Inc. | 6.53bn | 168.41m | 1.96bn | 7.60k | 12.16 | 2.06 | 7.61 | 0.3003 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
| Omnicell Inc | 1.08bn | -20.76m | 2.00bn | 3.65k | -- | 1.66 | 30.90 | 1.85 | -0.4558 | -0.4558 | 23.63 | 26.15 | 0.4818 | 5.64 | 4.20 | 296,013.40 | -0.9258 | 1.73 | -1.12 | 2.25 | 41.63 | 46.69 | -1.92 | 2.92 | 2.22 | -- | 0.322 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
| LeMaitre Vascular Inc | 205.62m | 37.68m | 2.03bn | 614.00 | 54.03 | 6.34 | 42.85 | 9.85 | 1.67 | 1.67 | 9.11 | 14.22 | 0.5964 | 1.13 | 7.19 | 334,887.60 | 10.93 | 9.02 | 11.81 | 9.93 | 67.70 | 65.83 | 18.32 | 15.45 | 5.86 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Premier Inc | 1.35bn | 119.54m | 2.04bn | 2.90k | 19.61 | 1.09 | 8.65 | 1.51 | 1.04 | 1.04 | 11.78 | 18.68 | 0.3976 | 5.85 | 3.07 | 464,262.40 | 3.15 | 7.08 | 4.10 | 8.95 | 65.96 | 61.29 | 7.93 | 16.05 | 0.8951 | -- | 0.2775 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| Rxsight Inc | 115.18m | -36.77m | 2.13bn | 374.00 | -- | 7.71 | -- | 18.46 | -1.01 | -1.01 | 3.14 | 6.95 | 0.46 | 2.08 | 5.90 | 307,962.60 | -14.69 | -- | -15.83 | -- | 66.26 | -- | -31.93 | -- | 13.34 | -- | 0.0005 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
| Irhythm Technologies Inc | 537.09m | -131.59m | 2.28bn | 2.00k | -- | 22.99 | -- | 4.25 | -4.26 | -4.26 | 17.40 | 3.18 | 0.7965 | 11.79 | 7.86 | 268,545.50 | -19.51 | -21.92 | -22.66 | -26.77 | 67.19 | 69.39 | -24.50 | -25.75 | 6.76 | -13.78 | 0.8667 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
| Conmed Corp | 1.28bn | 98.59m | 2.32bn | 4.00k | 23.89 | 2.63 | 13.62 | 1.82 | 3.15 | 3.15 | 40.81 | 28.61 | 0.5538 | 1.75 | 5.45 | 318,998.30 | 4.28 | 0.8972 | 4.94 | 1.02 | 55.32 | 54.95 | 7.73 | 1.65 | 1.13 | 4.20 | 0.5228 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Enovis Corp | 1.91bn | -107.11m | 2.51bn | 6.55k | -- | 0.7516 | 17.39 | 1.31 | -1.96 | -1.65 | 35.01 | 59.90 | 0.3872 | 1.53 | 5.52 | 292,209.20 | -2.16 | -0.3569 | -2.37 | -0.41 | 57.30 | 48.19 | -5.57 | -1.06 | 1.08 | 0.836 | 0.2902 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| Inari Medical Inc | 547.47m | -57.05m | 2.55bn | 1.30k | -- | 6.02 | -- | 4.67 | -0.9838 | -0.9838 | 9.43 | 7.29 | 0.9141 | 1.59 | 7.56 | 421,133.80 | -9.53 | -0.5941 | -11.39 | -0.6696 | 87.15 | 89.06 | -10.42 | -0.6295 | 1.45 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Myriad Genetics, Inc. | 802.20m | -155.20m | 2.57bn | 2.70k | -- | 3.47 | -- | 3.20 | -1.80 | -1.80 | 9.20 | 8.15 | 0.7061 | 10.21 | 6.99 | 297,111.10 | -13.66 | -- | -16.32 | -- | 69.06 | -- | -19.35 | -- | 1.78 | -113.89 | 0.0498 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
Data as of Sep 19 2024. Currency figures normalised to Patterson Companies Inc's reporting currency: US Dollar USD
43.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 11.67m | 13.24% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 9.26m | 10.50% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 3.66m | 4.15% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 3.23m | 3.66% |
| Allspring Global Investments LLCas of 30 Jun 2024 | 1.92m | 2.18% |
| River Road Asset Management LLCas of 30 Jun 2024 | 1.92m | 2.18% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.91m | 2.17% |
| Nordea Investment Management AB (Denmark)as of 30 Jun 2024 | 1.66m | 1.89% |
| Managed Account Advisors LLCas of 30 Jun 2024 | 1.64m | 1.86% |
| Brown Advisory LLCas of 30 Jun 2024 | 1.59m | 1.80% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
